DARTMOUTH-HITCHCOCK MEDICAL CENTER

- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1983-01-01
- Employees
- 10K
- Market Cap
- -
Clinical Trials
464
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (374 trials with phase data)• Click on a phase to view related trials
Efficacy of the I-CARE Digital Health Intervention
- Conditions
- Mental Health DisorderSuicide AttemptSuicidal IdeationEmergency Psychiatric
- First Posted Date
- 2025-09-02
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 173
- Registration Number
- NCT07150832
- Locations
- 🇺🇸
Yale, New Haven, Connecticut, United States
🇺🇸Dartmouth College, Hanover, New Hampshire, United States
🇺🇸Dartmouth Health, Lebanon, New Hampshire, United States
ASKids! Inpatient Agenda-Setting Study for Hospitalized Children With Medical Complexity
- Conditions
- Medical Complexity
- First Posted Date
- 2025-08-17
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT07127666
- Locations
- 🇺🇸
Dartmouth Hitchcock, Lebanon, New Hampshire, United States
Nutrition to Support Postoperative Recovery
- Conditions
- CognitionNutritional AssessmentNutritional InterventionPostoperative CarePostoperative Complications
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT07109505
Enabling Self-Care for Pessary Users in Rural Setting
- Conditions
- Pelvic Organ Prolapse
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT07084818
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
- Conditions
- Breast CancerAdjuvant TreatmentEarly Stage Breast Cancer
- Interventions
- Drug: SwitchOther: Guideline Directed Intervention (GDI)
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 62
- Registration Number
- NCT07071038
- Locations
- 🇺🇸
Dartmouth Cancer Center, Lebanon, New Hampshire, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 93
- Next
News
AI Revolutionizes Cancer Detection: Breakthroughs in Liquid Biopsies, Imaging, and Pathology
Advanced machine learning algorithms enable liquid biopsies for early lung cancer detection, potentially increasing annual lives saved from 600 to 12,000 in the United States through blood-based screening.